DavidSRussellMD, PhD

Clinical Trials

• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions Start of enrollment: 2009 Mar 01

  Completed

  Phase 1

• Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01

  Terminated

  Phase 3

• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects Start of enrollment: 2014 Feb 01

  Completed

  Phase 1

• Efficacy of Isradipine in Early Parkinson Disease Start of enrollment: 2014 Nov 01

  Completed

  Phase 3

• Systemic Synuclein Sampling Study (S4) Start of enrollment: 2015 Oct 01

  Completed

• Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™ Start of enrollment: 2020 Sep 10

  Active, not recruiting

• Join now to see all